A detailed history of Advisor Resource Council transactions in Alkermes Plc. stock. As of the latest transaction made, Advisor Resource Council holds 60,952 shares of ALKS stock, worth $1.7 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
60,952
Holding current value
$1.7 Million
% of portfolio
0.15%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 21, 2025

BUY
$28.08 - $36.0 $1.71 Million - $2.19 Million
60,952 New
60,952 $2.01 Million
Q2 2021

Aug 13, 2021

BUY
$18.78 - $25.15 $37 - $50
2 New
2 $0

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.57B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Advisor Resource Council Portfolio

Follow Advisor Resource Council and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Resource Council, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Resource Council with notifications on news.